Functional and structural analysis of C-terminal BRCA1 missense variants.
Germline inactivating mutations in BRCA1 and BRCA2 genes are responsible for Hereditary Breast and Ovarian Cancer Syndrome (HBOCS). Genetic testing of these genes is available, although approximately 15% of tests identify variants of uncertain significance (VUS). Classification of these variants int...
Main Authors: | Francisco Quiles, Juana Fernández-Rodríguez, Roberto Mosca, Lídia Feliubadaló, Eva Tornero, Joan Brunet, Ignacio Blanco, Gabriel Capellá, Miquel Àngel Pujana, Patrick Aloy, Alvaro Monteiro, Conxi Lázaro |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3629201?pdf=render |
Similar Items
-
Analysis of <it>SLX4/FANCP </it>in non-<it>BRCA1/2</it>-mutated breast cancer families
by: Fernández-Rodríguez Juana, et al.
Published: (2012-03-01) -
Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.
by: Renato S Carvalho, et al.
Published: (2014-01-01) -
Functional impact of missense variants in BRCA1 predicted by supervised learning.
by: Rachel Karchin, et al.
Published: (2007-02-01) -
Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2.
by: Eric Tram, et al.
Published: (2013-01-01) -
In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing
by: Kok-Siong Poon
Published: (2021-05-01)